RESEARCHER PROFILE
А. С. Колбин
← Back to St Petersburg University
А
St Petersburg University
А. С. Колбин works in Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Antibiotic Use and Resistance, Medical and Pharmaceutic Studies, Pharmacovigilance and Adverse Drug Reactions. Recorded institutional associations include St Petersburg University, First Pavlov State Medical University of St. Petersburg.
401Publications
612Citations
9H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia
2014 · 44 citationsA mathematical model for predicting the development of bacterial resistance based on the relationship between the level of antimicrobial resistance and the volume of antibiotic consumption
2017 · 43 citationsAssessing routine healthcare pattern for type 2 diabetes mellitus in Russia: the results of рharmacoepidemiological study (FORSIGHT-DM2)
2016 · 29 citationsCost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)
2018 · 24 citationsMUCORMYCOSIS IN ONCOHEMATOLOGY PATIENTS (results of the prospective study)
2017 · 16 citationsReview of real-world data study
2021 · 15 citationsSocioeconomic and global burden of COVID-19
2021 · 14 citationsRetrospective surveillance of antibiotic use in maternity wards and neonatal intensive care units in Saint Petersburg, Russia
2018 · 10 citationsEPIDEMIOLOGICAL, CLINICAL AND FINANCIAL COMPONENTS OF RESULTS OF LONGTERM ANTIRETROVIRAL THERAPY OF PATIENTS WITH HIVINFECTION
2020 · 10 citationsSocio-economic burden of COVID-19 in the Russian Federation
2020 · 9 citations«DIARISK» — the first national prediabetes and diabetes mellitus type 2 risk calculator
2021 · 9 citationsA brief report of real-world evidence development (RWD/RWE) in 2021: United States, Russia, and the Eurasian Economic Union (EAEU)
2022 · 9 citationsWhat should be considered if you decide to build your own mathematical model for predicting the development of bacterial resistance? Recommendations based on a systematic review of the literature
2015 · 8 citationsСистема фармаконадзора в Евразийском экономическом союзе
2018 · 8 citationsThe social-economic burden of spinal muscular atrophy in Russia
2021 · 8 citationsCOMPARATIVE REVIEW OF METHODOLOGIES FOR ESTIMATING THE COST OF ADVERSE DRUG REACTIONS IN THE RUSSIAN FEDERATION AND BRAZIL
2021 · 8 citationsResolution based on the results of the conference: "RWD/ RWE – Research Tools of Real-World Clinical Practice Today and Tomorrow"
2021 · 8 citationsDrug therapy for obesity in the Russian Federation: pharmacoepidemiological study
2022 · 8 citationsInvasive aspergillosis: results of multicenter study
2014 · 7 citationsCOVID-19 and clinical pharmacology
2020 · 7 citationsNonsteroidal anti-inflammatory drugs’ adverse drug reactions: 10 years of national database data
2022 · 7 citationsThe real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies
2022 · 7 citationsAntimicrobial drug consumption in the Russian Federation (2008–2022): pharmacoepidemiological study
2023 · 7 citationsImproving data retrieval quality: Evidence based medicine perspective
2015 · 6 citationsQuantitative and qualitative evaluation of the use of nonsteroidal anti-inflammatory drugs in the Russian Federation over 10 years
2022 · 6 citations
